From September 1991 to December 1992, a prospective study was conducte
d to determine the risk factors and residual risk of rebleeding, and t
he evolutionary endoscopic changes in peptic ulcers that rebled. Emerg
ency endoscopies were performed on 452 patients with haematemesis or a
melaena, or both within 24 hours of admission. If the lesions were ac
tively bleeding, then the patients were treated with injection sclerot
herapy. A multivariate analysis of clinical, laboratory, and endoscopi
c variables of 204 patients with ulcer bleeding showed that hypovolaem
ic shock, a non-bleeding visible vessel, and an adherent clot on the u
lcer base were independently significant in predicting rebleeding (p <
0.05). Considering these three factors according to the estimates of
their regression coefficients showed that a non-bleeding visible vesse
l was the strongest predictor of rebleeding. The study of the residual
risk of rebleeding after admission showed that most rebleeding episod
es (94.1%), including all associated with hypovolaemic shock, surgical
treatment, and death, occurred within 96 hours of admission. After th
is time, the residual risk of rebleeding was less than 1%. Study of th
e changes in endoscopic findings before and after rebleeding illustrat
ed that all ulcers with a visible vessel or adherent clot showed at fo
llow up endoscopy were derived from ulcers with initial major stigmata
. It is concluded that hypovolaemic shock, a non-bleeding visible vess
el, and an adherent clot on an ulcer base are of independent significa
nce in predicting rebleeding. Observation for 96 hours is sufficient t
o detect most rebleeding episodes after an initial bleed from peptic u
lcer.